UTAH MEDICAL PRODUCTS, INC. Accounts Payable
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Accounts Payable of $876.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $876.00K.
- 2026-03-31: Accounts Payable, Current $1.19M.
- 2025-12-31: Accounts Payable, Current $911.00K.
- 2025-09-30: Accounts Payable, Current $768.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $876.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.19M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $911.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $768.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $737.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $914.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $696.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $999.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $834.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $998.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $769.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $511.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.34M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.03M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-26 |
| 2022-09-30 | $1.29M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $818.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.45M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $761.00K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $1.03M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.19M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $839.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $788.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $651.00K 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | $560.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.06M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.10M 10-K · filed 2021-03-26 |
| 2019-09-30 | $785.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $854.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.85M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $975.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $668.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $979.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.08M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $934.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $1.13M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $984.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.02M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $906.00K 10-K · filed 2018-03-06 |
| 2016-09-30 | $943.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $1.06M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $978.00K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $649.00K 10-K · filed 2017-03-08 |
| 2015-09-30 | $922.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $932.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $807.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $929.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $1.02M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $877.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $758.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $773.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $1.21M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $942.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $1.14M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $1.00M 10-K · filed 2014-03-12 |
| 2012-09-30 | $1.18M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $1.35M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $1.25M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $925.00K 10-K · filed 2013-03-07 |
| 2011-09-30 | $1.70M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $2.00M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $398.00K 10-K/A · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |